Henry Schein to Present at Investor Conferences in June 2024
MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and... Read more.
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused... Read more.
Ault Alliance Achieves Profitability in the First Quarter of 2024; Revenue Increases by 55% to $45 Million
LAS VEGAS–(BUSINESS WIRE)–$AGREE #AGREE—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”),... Read more.
LBAi W-Gate: a New Era for Perimeter Protection, With Artificial Intelligence
LIMONEST, France–(BUSINESS WIRE)–LBA, manufacturer of automatic bollards and automatic barriers, announces the launch of its brand-new, breakthrough... Read more.
KAYTUS Introduces KR1280V2 – a 1U Server with 32 E1.S SSDs, Boosting I/O Performance for LLM Training
The KR1280V2, a 1U 2-socket high-density server, is ideal for compute-intensive applications like high-performance computing and high-frequency trading. It meets... Read more.
Battelle’s Innovations in Climate Resilience Conference Convenes Experts, Industry Leaders
COLUMBUS, Ohio–(BUSINESS WIRE)–The third annual Battelle Innovations in Climate Resilience Conference (ICR) provided a platform for leaders and experts... Read more.
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
Company asserts that Geneoscopy will infringe patented technology central to its Cologuard colorectal cancer screening test MADISON, Wis.–(BUSINESS WIRE)–Exact... Read more.
MTTI Reports on 225Ac-EBTATE and 177Lu-EBTATE Radiopharmaceuticals at 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
WEST CHESTER, Pa.–(BUSINESS WIRE)–Molecular Targeting Technologies, Inc. (MTTI), will update findings on both 177Lu-EBTATE clinical and 225Ac-EBTATE... Read more.
Ellodi Pharmaceuticals Announces FLUTE-2 Data to be Presented at DDW 2024 with APT-1011 in Patients with Eosinophilic Esophagitis
APT-1011 Demonstrated a Higher Rate of Complete Symptomatic Response at 12-Weeks Compared to Placebo APT-1011 Demonstrated Improvement in Fibrostenotic Features... Read more.
Immersive Labs Unveils New ‘Dark Side of GenAI’ Report about How People Trick Chatbots into Exposing Company Secrets
Analysis of prompt injection techniques reveals organizations are at risk as GenAI bots are susceptible to attacks by users of all skill levels, not just experts... Read more.